{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:21:06Z","timestamp":1779315666328,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T00:00:00Z","timestamp":1330387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10552-012-9927-8","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T06:11:57Z","timestamp":1330323117000},"page":"609-616","source":"Crossref","is-referenced-by-count":32,"title":["A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers"],"prefix":"10.1007","volume":"23","author":[{"given":"E. S.","family":"Schernhammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Giobbie-Hurder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Gantman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Savoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Scheib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,28]]},"reference":[{"key":"9927_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J (2010) Ward E cancer statistics. CA Cancer J Clin 60:277\u2013300","journal-title":"CA Cancer J Clin"},{"key":"9927_CR2","doi-asserted-by":"crossref","unstructured":"Breen N, Gentleman JF, Schiller JS (2011) Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer 117(10):2209\u20132218","DOI":"10.1002\/cncr.25679"},{"key":"9927_CR3","doi-asserted-by":"crossref","unstructured":"Swain SM (2011) Chemotherapy: updates and new perspectives. Oncologist 15(5):8\u201317","DOI":"10.1634\/theoncologist.2011-S1-30"},{"key":"9927_CR4","doi-asserted-by":"crossref","unstructured":"Rivera-Guevara C, Camacho J (2011) Tamoxifen and its new derivatives in cancer research. Recent Pat Anticancer Drug Discov 6(2):237\u2013245","DOI":"10.2174\/157489211795328486"},{"key":"9927_CR5","doi-asserted-by":"crossref","unstructured":"Vijayalaxmi B, Thomas CR Jr, Reiter RJ, Herman TS (2002) Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 20:2575\u20132601","DOI":"10.1200\/JCO.2002.11.004"},{"key":"9927_CR6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1158\/1055-9965.EPI-09-1229","volume":"19","author":"ES Schernhammer","year":"2010","unstructured":"Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E et al (2010) Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 19:729\u2013737","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9927_CR7","doi-asserted-by":"crossref","unstructured":"Herxheimer A, Petrie KJ (2002) Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev 2:CD001520","DOI":"10.1002\/14651858.CD001520"},{"key":"9927_CR8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/oxfordjournals.aje.a114569","volume":"125","author":"RG Stevens","year":"1987","unstructured":"Stevens RG (1987) Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125:556\u2013561","journal-title":"Am J Epidemiol"},{"key":"9927_CR9","first-page":"637","volume":"15","author":"S Cos","year":"2000","unstructured":"Cos S, Sanchez-Barcelo EJ (2000) Melatonin, experimental basis for a possible application in breast cancer prevention and treatment. Histol Histopathol 15:637\u2013647","journal-title":"Histol Histopathol"},{"key":"9927_CR10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/frne.1999.0194","volume":"21","author":"S Cos","year":"2000","unstructured":"Cos S, Sanchez-Barcelo EJ (2000) Melatonin and mammary pathological growth. Front Neuroendocrinol 21:133\u2013170","journal-title":"Front Neuroendocrinol"},{"key":"9927_CR11","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jnci\/83.20.1488","volume":"83","author":"VC Jordan","year":"1991","unstructured":"Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC (1991) Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst 83:1488\u20131491","journal-title":"J Natl Cancer Inst"},{"key":"9927_CR12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"T Key","year":"2002","unstructured":"Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606\u2013616","journal-title":"J Natl Cancer Inst"},{"key":"9927_CR13","doi-asserted-by":"crossref","unstructured":"Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530\u2013542","DOI":"10.1016\/S1470-2045(10)70095-4"},{"key":"9927_CR14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jc.74.1.108","volume":"74","author":"BC Voordouw","year":"1992","unstructured":"Voordouw BC, Euser R, Verdonk RE, Alberda BT, de Jong FH, Drogendijk AC et al (1992) Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab 74:108\u2013117","journal-title":"J Clin Endocrinol Metab"},{"key":"9927_CR15","first-page":"17","volume":"23","author":"M Pawlikowski","year":"2002","unstructured":"Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M (2002) Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuro Endocrinol Lett 23:17\u201319","journal-title":"Neuro Endocrinol Lett"},{"key":"9927_CR16","first-page":"309","volume":"23","author":"R Luboshitzky","year":"2002","unstructured":"Luboshitzky R, Herer P, Shen-Orr Z (2002) Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women. Neuro Endocrinol Lett 23:309\u2013313","journal-title":"Neuro Endocrinol Lett"},{"key":"9927_CR17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1289\/ehp.01109501","volume":"109","author":"C Graham","year":"2001","unstructured":"Graham C, Cook MR (2001) Examination of the melatonin hypothesis in women exposed at night to EMF or bright light. Environ Health Perspect 109:501\u2013507","journal-title":"Environ Health Perspect"},{"key":"9927_CR18","first-page":"163","volume":"11","author":"M Ishido","year":"2004","unstructured":"Ishido M (2004) Transient inhibition of synergistically insulin-like growth factor-1- and bisphenol A-induced proliferation of estrogen receptor alpha (ERalpha)-positive human breast cancer MCF-7 cells by melatonin. Environ Sci 11:163\u2013170","journal-title":"Environ Sci"},{"key":"9927_CR19","first-page":"211","volume":"37","author":"Z Ostrowska","year":"2003","unstructured":"Ostrowska Z, Kos-Kudla B, Nowak M, Swietochowska E, Marek B, Gorski J et al (2003) The relationship between bone metabolism, melatonin and other hormones in sham-operated and pinealectomized rats. Endocr Regul 37:211\u2013224","journal-title":"Endocr Regul"},{"key":"9927_CR20","unstructured":"Kajdaniuk D, Marek B, Kos-Kudla B, Zwirska-Korczala K, Ostrowska Z, Buntner B et al. (2002) Does the negative correlation found in breast cancer patients between plasma melatonin and insulin-like growth factor-I concentrations imply the existence of an additional mechanism of oncostatic melatonin influence involved in defense? Med Sci Monit 8:CR457\u2013CR461"},{"key":"9927_CR21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF03346890","volume":"20","author":"AA Sinisi","year":"1997","unstructured":"Sinisi AA, Pasquali D, D\u2019Apuzzo A, Esposito D, Venditto T, Criscuolo T et al (1997) Twenty-four hour melatonin pattern in acromegaly: effect of acute octreotide administration. J Endocrinol Invest 20:128\u2013133","journal-title":"J Endocrinol Invest"},{"key":"9927_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1005743626105","volume":"42","author":"IM Holdaway","year":"1997","unstructured":"Holdaway IM, Mason BH, Gibbs EE, Rajasoorya C, Lethaby A, Hopkins KD et al (1997) Seasonal variation in the secretion of mammotrophic hormones in normal women and women with previous breast cancer. Breast Cancer Res Treat 42:15\u201322","journal-title":"Breast Cancer Res Treat"},{"key":"9927_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2265.2001.01232.x","volume":"54","author":"A Cagnacci","year":"2001","unstructured":"Cagnacci A, Arangino S, Renzi A, Paoletti AM, Melis GB, Cagnacci P et al (2001) Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol (Oxf) 54:339\u2013346","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9927_CR24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/bjc.1995.164","volume":"71","author":"P Lissoni","year":"1995","unstructured":"Lissoni P, Barni S, Meregalli S, Fossati V, Cazzaniga M, Esposti D et al (1995) Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 71:854\u2013856","journal-title":"Br J Cancer"},{"issue":"Suppl 1","key":"9927_CR25","first-page":"17","volume":"23","author":"M Pawlikowski","year":"2002","unstructured":"Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M (2002) Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuro Endocrinol Lett 23(Suppl 1):17\u201319","journal-title":"Neuro Endocrinol Lett"},{"key":"9927_CR26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-079X.2001.300105.x","volume":"30","author":"C Siegrist","year":"2001","unstructured":"Siegrist C, Benedetti C, Orlando A, Beltran JM, Tuchscherr L, Noseda CM et al (2001) Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle-aged, and elderly patients. J Pineal Res 30:34\u201342","journal-title":"J Pineal Res"},{"key":"9927_CR27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-079X.2005.00258.x","volume":"39","author":"E Mills","year":"2005","unstructured":"Mills E, Wu P, Seely D, Guyatt G (2005) Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res 39:360\u2013366","journal-title":"J Pineal Res"},{"key":"9927_CR28","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0959-8049(99)00159-8","volume":"35","author":"P Lissoni","year":"1999","unstructured":"Lissoni P, Barni S, Mandala M, Ardizzoia A, Paolorossi F, Vaghi M et al (1999) Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer 35:1688\u20131692","journal-title":"Eur J Cancer"},{"key":"9927_CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-079X.2003.00032.x","volume":"35","author":"P Lissoni","year":"2003","unstructured":"Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G (2003) Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 35:12\u201315","journal-title":"J Pineal Res"},{"key":"9927_CR30","first-page":"334","volume":"29","author":"AL Morera","year":"2001","unstructured":"Morera AL, Henry M, de La Varga M (2001) Safety in melatonin use. Actas Esp Psiquiatr 29:334\u2013337","journal-title":"Actas Esp Psiquiatr"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-9927-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-012-9927-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-9927-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T15:20:24Z","timestamp":1561389624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-012-9927-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,28]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["9927"],"URL":"https:\/\/doi.org\/10.1007\/s10552-012-9927-8","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,28]]}}}